Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 2 2Phase 1/2 2

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 3Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Oligodendroglioma 1Melanoma 1Lung Neoplasms 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Ependymoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Temozolomide 38Radiotherapy 22Radiosurgery 22Radiation 11Magnetic Resonance Spectroscopy 11Irinotecan 11Cyclophosphamide 11Etoposide 10Surgical Procedures, Operative 9Erlotinib Hydrochloride 9Carmustine 9pembrolizumab 8Filgrastim 8Carboplatin 8Bevacizumab 7Vincristine 6Sorafenib 6O(6)-benzylguanine 6Nivolumab 6Flucytosine 6Aminolevulinic Acid 6temsirolimus 5sargramostim 5Vorinostat 5Trastuzumab 5Topotecan 5Lomustine 5Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5Everolimus 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Brain Neoplasms × alovudine × Clear all
NCT00813566 2022-04-27

Multi-Tracer PET Assessment of Primary Brain Tumors

University of Utah

Phase 1 Completed
11 enrolled
CNS

Brain Neoplasms, Neoplasms

NCT01480050 2019-05-22

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
28 enrolled
CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00553748 2008-07-03

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Siemens Molecular Imaging

Phase 1 Completed
11 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡